ScienceDaily: Health & Medicine News |
- Cows fed flaxseed produce more nutritious dairy products
- Daily antiseptic baths slash risk of bloodstream infections in critically ill children
- Potential benefits and threats of nanotechnology research
- Potential of differentiated iPS cells in cell therapy without immune rejection
- How to predict the future of technology?
- Research may lead to new strategies against sepsis
- New target for rheumatoid arthritis drugs
- Emotional stress reduces effectiveness of prostate cancer therapies in animal model
- New tool for mining bacterial genome for novel drugs
| Cows fed flaxseed produce more nutritious dairy products Posted: 26 Jan 2013 06:27 AM PST Dairy cows that are fed flaxseed produce more nutritious milk, with more omega-3 fatty acids and less saturated fat. |
| Daily antiseptic baths slash risk of bloodstream infections in critically ill children Posted: 26 Jan 2013 06:26 AM PST Daily baths with an ordinary antibacterial cleanser can safely reduce the risk of dangerous bloodstream infections in critically ill children, according to a trial conducted in five pediatric hospitals. |
| Potential benefits and threats of nanotechnology research Posted: 25 Jan 2013 12:48 PM PST A new article tackles the complex "dual-use" aspect of nanotechnology research. |
| Potential of differentiated iPS cells in cell therapy without immune rejection Posted: 25 Jan 2013 12:48 PM PST A new study shows that tissues derived from induced pluripotent stem (iPS) cells in an experimental model were not rejected when transplanted back into genetically identical recipients. |
| How to predict the future of technology? Posted: 25 Jan 2013 11:22 AM PST Forget Moore's Law. USC Marshall, Emory University and University of Michigan researchers define new ways to evaluate new technologies. The bread and butter of investing for Silicon Valley tech companies is stale. Instead, a new method of predicting the evolution of technology could save tech giants millions in research and development or developments of new products -- and help analysts and venture capitalists determine which companies are on the right track. |
| Research may lead to new strategies against sepsis Posted: 25 Jan 2013 11:22 AM PST Scientists are closer to solving a long-standing mystery in sepsis, a complex, often life-threatening condition. By blocking the activity of a protein in cells that line blood vessels in mice, they have halted a cascade of cellular events that culminates in out-of-control inflammation, and protected lungs from damage. The findings provide new insights into molecular details underlying sepsis and its effects on lungs, and may lead to new treatments. |
| New target for rheumatoid arthritis drugs Posted: 25 Jan 2013 11:20 AM PST Researchers have identified a potential new target for drugs to treat patients with rheumatoid arthritis. Efforts to develop drugs that hone in on this new target are underway. |
| Emotional stress reduces effectiveness of prostate cancer therapies in animal model Posted: 25 Jan 2013 11:20 AM PST Not surprisingly, a cancer diagnosis creates stress. And patients with prostate cancer show higher levels of anxiety compared to other cancer patients. A new study indicates that stress is not just an emotional side effect of the diagnosis; it also can reduce the effectiveness of prostate cancer drugs and accelerate the development of prostate cancer. |
| New tool for mining bacterial genome for novel drugs Posted: 25 Jan 2013 11:20 AM PST Biochemists have discovered that the process bacteria undergo when they become drug resistant can act as a powerful tool for drug discovery. |
| You are subscribed to email updates from ScienceDaily: Health & Medicine News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
ليست هناك تعليقات:
إرسال تعليق